KR20010099629A - Ｔａｎ-1057 유도체 - Google Patents
Ｔａｎ-1057 유도체 Download PDFInfo
- Publication number
- KR20010099629A KR20010099629A KR1020017002417A KR20017002417A KR20010099629A KR 20010099629 A KR20010099629 A KR 20010099629A KR 1020017002417 A KR1020017002417 A KR 1020017002417A KR 20017002417 A KR20017002417 A KR 20017002417A KR 20010099629 A KR20010099629 A KR 20010099629A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- group
- rti
- compounds
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19838998A DE19838998A1 (de) | 1998-08-27 | 1998-08-27 | Neue Naturstoffderivate |
| DE19838998.1 | 1998-08-27 | ||
| PCT/EP1999/006124 WO2000012484A1 (de) | 1998-08-27 | 1999-08-20 | Tan-1057 derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20010099629A true KR20010099629A (ko) | 2001-11-09 |
Family
ID=7878913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020017002417A Withdrawn KR20010099629A (ko) | 1998-08-27 | 1999-08-20 | Ｔａｎ-1057 유도체 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6617332B1 (enExample) |
| EP (1) | EP1117652B1 (enExample) |
| JP (1) | JP4533535B2 (enExample) |
| KR (1) | KR20010099629A (enExample) |
| CN (1) | CN1324348A (enExample) |
| AT (1) | ATE267816T1 (enExample) |
| AU (1) | AU759618B2 (enExample) |
| BG (1) | BG105275A (enExample) |
| BR (1) | BR9913337A (enExample) |
| CA (1) | CA2342102C (enExample) |
| DE (2) | DE19838998A1 (enExample) |
| EE (1) | EE200100125A (enExample) |
| ES (1) | ES2219105T3 (enExample) |
| HK (1) | HK1041884A1 (enExample) |
| HR (1) | HRP20010135A2 (enExample) |
| HU (1) | HUP0103316A3 (enExample) |
| ID (1) | ID28365A (enExample) |
| IL (1) | IL141325A0 (enExample) |
| NO (1) | NO20010940L (enExample) |
| NZ (1) | NZ510153A (enExample) |
| PL (1) | PL346143A1 (enExample) |
| SK (1) | SK2622001A3 (enExample) |
| TR (1) | TR200100637T2 (enExample) |
| WO (1) | WO2000012484A1 (enExample) |
| ZA (1) | ZA200101038B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1113008A1 (en) * | 1999-12-29 | 2001-07-04 | Pfizer Products Inc. | 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives useful as antibacterial and antiprotozoal agents |
| US20040204404A1 (en) * | 2002-09-30 | 2004-10-14 | Robert Zelle | Human N-type calcium channel blockers |
| EP2220093A4 (en) * | 2007-12-20 | 2011-06-22 | Reddys Lab Ltd Dr | METHOD FOR THE PRODUCTION OF SITAGLIPTIN AND PHARMACEUTICAL ACCEPTABLE SALTS THEREOF |
| JP5725561B2 (ja) | 2009-10-15 | 2015-05-27 | 国立大学法人徳島大学 | ジエチレントリアミン五酢酸誘導体の製造方法およびジエチレントリアミン五酢酸誘導体 |
| EA201270568A1 (ru) | 2009-10-16 | 2012-11-30 | Риб-Экс Фармасьютикалз, Инк. | Антимикробные композиции и способы их получения и применения |
| NZ599291A (en) | 2009-10-16 | 2014-06-27 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
| CN104628729B (zh) * | 2009-10-16 | 2018-11-06 | 梅琳塔治疗公司 | 抗微生物化合物和其制备和使用方法 |
| NZ599290A (en) * | 2009-10-16 | 2014-10-31 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
| MY173518A (en) | 2011-04-15 | 2020-01-30 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
| RU2475479C1 (ru) * | 2011-12-23 | 2013-02-20 | Федеральное государственное бюджетное учреждение Министерства здравоохранения и социального развития Российской Федерации "Медицинский радиологический научный центр" (ФГБУ МРНЦ Минздравсоцразвития России) | Вазоконстрикторное средство |
| EP3038623A4 (en) | 2013-09-09 | 2017-04-19 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
| SG10201801956SA (en) | 2013-09-09 | 2018-04-27 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
| BR112017019349A2 (pt) | 2015-03-11 | 2018-06-05 | Melinta Therapeutics Inc | compostos antimicrobianos e métodos de fabricação e uso dos mesmos |
| US11098047B2 (en) | 2016-05-06 | 2021-08-24 | BioVersys AG | Antimicrobials and methods of making and using same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2873340B2 (ja) * | 1988-04-29 | 1999-03-24 | 武田薬品工業株式会社 | 抗生物質ｔａｎ―１０５７，その製造法および用途 |
| US6110925A (en) | 1997-08-07 | 2000-08-29 | Research Corporation Technologies, Inc. | Antibiotic for methicillin resistant bacteria |
-
1998
- 1998-08-27 DE DE19838998A patent/DE19838998A1/de not_active Ceased
-
1999
- 1999-08-20 TR TR2001/00637T patent/TR200100637T2/xx unknown
- 1999-08-20 DE DE59909607T patent/DE59909607D1/de not_active Expired - Lifetime
- 1999-08-20 ES ES99968234T patent/ES2219105T3/es not_active Expired - Lifetime
- 1999-08-20 JP JP2000567514A patent/JP4533535B2/ja not_active Expired - Fee Related
- 1999-08-20 CA CA002342102A patent/CA2342102C/en not_active Expired - Fee Related
- 1999-08-20 WO PCT/EP1999/006124 patent/WO2000012484A1/de not_active Ceased
- 1999-08-20 EE EEP200100125A patent/EE200100125A/xx unknown
- 1999-08-20 IL IL14132599A patent/IL141325A0/xx unknown
- 1999-08-20 ID IDW20010483A patent/ID28365A/id unknown
- 1999-08-20 NZ NZ510153A patent/NZ510153A/xx unknown
- 1999-08-20 AT AT99968234T patent/ATE267816T1/de not_active IP Right Cessation
- 1999-08-20 HK HK02103758.4A patent/HK1041884A1/zh unknown
- 1999-08-20 AU AU10099/00A patent/AU759618B2/en not_active Ceased
- 1999-08-20 KR KR1020017002417A patent/KR20010099629A/ko not_active Withdrawn
- 1999-08-20 HR HR20010135A patent/HRP20010135A2/hr not_active Application Discontinuation
- 1999-08-20 SK SK262-2001A patent/SK2622001A3/sk unknown
- 1999-08-20 CN CN99812643A patent/CN1324348A/zh active Pending
- 1999-08-20 PL PL99346143A patent/PL346143A1/xx not_active Application Discontinuation
- 1999-08-20 BR BR9913337-7A patent/BR9913337A/pt not_active IP Right Cessation
- 1999-08-20 HU HU0103316A patent/HUP0103316A3/hu unknown
- 1999-08-20 EP EP99968234A patent/EP1117652B1/de not_active Expired - Lifetime
- 1999-08-20 US US09/763,711 patent/US6617332B1/en not_active Expired - Fee Related
-
2001
- 2001-02-07 ZA ZA200101038A patent/ZA200101038B/en unknown
- 2001-02-20 BG BG105275A patent/BG105275A/xx unknown
- 2001-02-23 NO NO20010940A patent/NO20010940L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1117652A1 (de) | 2001-07-25 |
| AU1009900A (en) | 2000-03-21 |
| ZA200101038B (en) | 2002-02-07 |
| JP4533535B2 (ja) | 2010-09-01 |
| BR9913337A (pt) | 2001-05-15 |
| SK2622001A3 (en) | 2001-11-06 |
| ATE267816T1 (de) | 2004-06-15 |
| EE200100125A (et) | 2002-06-17 |
| BG105275A (en) | 2001-11-30 |
| JP2002523496A (ja) | 2002-07-30 |
| HRP20010135A2 (en) | 2002-02-28 |
| ID28365A (id) | 2001-05-17 |
| EP1117652B1 (de) | 2004-05-26 |
| NZ510153A (en) | 2002-12-20 |
| DE59909607D1 (de) | 2004-07-01 |
| CN1324348A (zh) | 2001-11-28 |
| US6617332B1 (en) | 2003-09-09 |
| CA2342102C (en) | 2008-10-28 |
| AU759618B2 (en) | 2003-04-17 |
| NO20010940D0 (no) | 2001-02-23 |
| DE19838998A1 (de) | 2000-03-09 |
| HK1041884A1 (zh) | 2002-07-26 |
| IL141325A0 (en) | 2002-03-10 |
| ES2219105T3 (es) | 2004-11-16 |
| PL346143A1 (en) | 2002-01-28 |
| TR200100637T2 (tr) | 2001-10-22 |
| CA2342102A1 (en) | 2000-03-09 |
| WO2000012484A1 (de) | 2000-03-09 |
| HUP0103316A3 (en) | 2002-06-28 |
| NO20010940L (no) | 2001-04-23 |
| HUP0103316A2 (hu) | 2002-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2266901C2 (ru) | 4-пиримидинил-n-ацил-l-фенилаланины и фармацевтическая композиция | |
| CN104640857B (zh) | 作为整合素拮抗剂的β氨基酸衍生物 | |
| US6617332B1 (en) | Tan-1057 derivatives | |
| JP2002511462A (ja) | ビトロネクチンアンタゴニストとしてのヘテロ環式グリシルβ−アラニン誘導体 | |
| SK49194A3 (en) | Urethanes and ureas which are inducing production of cytokine | |
| KR100758441B1 (ko) | 항균제용 2―히드록시―무틸린 카르바메이트 유도체 | |
| KR20130065728A (ko) | Ahr 활성화제로서의 1,2-디히드로-4-히드록시-2-옥소-퀴놀린-3-카르복사닐리드 | |
| US6100423A (en) | Amino benzenepropanoic acid compounds and derivatives thereof | |
| WO2008142623A2 (en) | Tumor necrosis factor - alpha inhibitors | |
| JP2002538131A (ja) | キラルβ−アミノエステルの調製方法 | |
| KR0139946B1 (ko) | 신규한 피리돈 카르본산 유도체 및 그의 제조방법 | |
| CZ2001742A3 (cs) | Nové deriváty přírodních látek | |
| JPS63277652A (ja) | δ−ハイドロキシ−β−リジン誘導体およびその製造法 | |
| MXPA01002058A (en) | Tan-1057 derivatives | |
| CN101171236A (zh) | 抗肿瘤的四氢嘧啶 | |
| EP4104902A1 (en) | Compound and drug containing same | |
| WO2001002364A1 (en) | New npy antagonists | |
| CN111065635B (zh) | 作为mth1抑制剂的新型嘧啶衍生物 | |
| JP2002308870A (ja) | チオフェン骨格を有する抗菌剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20010226 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |